Equity
€117,864 ▼ 40.5%
JS HandSurgery paid out €221,622 in dividends. That is 157% of the 2025 profit.
JS HandSurgery
Lifetime
4 annual accounts with figures on one time axispeak €213,828 (2025)
€213,828▲ 61.9%
peak €141,434 (2025)
€141,434▲ 76.4%
peak €198,052 (2024)
€117,864▼ 40.5%
€283,622▲ 195%
Board1 name since 2022
1 directorSTULKO Jennifer Bénédicte Ghislaine
Documentsfilings and deeds
25-06-202636 days before the deadline
2025micro format
Gross margin from €132,046 to €213,828Result from €80,188 to €141,434Dividend €221,622Equity from €198,052 to €117,864Debts from €96,238 to €283,622Cash from €99,901 to €228,099
Key points
from the 2025 annual accountsResult
€141,434 ▲ 76.4%
The result rose in 2025 from €80,188 to €141,434.
Turnover
≈ €540,000 estimated
The micro format states no turnover.
Debts
€283,622 ▲ 195%
Debts rose by €187,384 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Liquidity
1.21 was 2.64 in 2024
Short-term debts rose from €75,875 to €273,470.
Filings
4 annual accounts 3 late
The 2022 accounts came latest: 30 days after the end of the period.
Checked score
85
Excellent
Financially stronger than 48% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.4%▲ +0.1 percentage points vs 03-2025
05-2025: 0.4%● unchanged vs 04-2025
06-2025: 0.4%● unchanged vs 05-2025
07-2025: 0.4%● unchanged vs 06-2025
08-2025: 0.9%▲ +0.5 percentage points vs 07-2025highest value
09-2025: 0.1%▼ -0.8 percentage points vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025lowest value
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.4%▲ +0.3 percentage points vs 02-2026
04-2026: 0.4%● unchanged vs 03-2026
05-2026: 0.6%▲ +0.2 percentage points vs 04-2026
06-2026: 0.7%▲ +0.1 percentage points vs 05-2026
07-2026: 0.6%▼ -0.1 percentage points vs 06-2026
08-2026: 0.8%▲ +0.2 percentage points vs 07-2026
09-2026: 0.8%● unchanged vs 08-2026
10-2026: 0.3%▼ -0.5 percentage points vs 09-2026
11-2026: 0.3%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
1 change of registered office in 24 months
Founded in 2022
lowers risk
Size: total assets €401,486
Figures for financial year 2025 (filed on 25-06-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 33% of them on solvency, 60% on liquidity, 90% on profitability and 11% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 7,976 companies had the same profile as JS HandSurgery has now. Each dot stands for 20 companies, two years later.
94.4%
were still trading
1.8%
stopped another way
3.6%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of JS HandSurgery itself is lower: 0.3% within 12 months. It rests on far more data about JS HandSurgery than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,976 companies, not a prediction for JS HandSurgery. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.21 (2.64 in 2024), below the usual 1.5. Short-term debt is 68.1% and cash 56.8% of total assets. 70.6% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-06-2026, 36 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
36 days early
2024
27 days late
2023
29 days late
2022
30 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 4 accounts on average 13 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 August (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- STULKO Jennifer Bénédicte Ghislaine 100 sharesdeed of 12-04-2022
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0784674669
Registered office moved from Liège to Neupré
New registered office: Rue des Mésanges 11, 4121 Neupré · Previous registered office: Avenue du Petit-Bourgogne 84, 4000 Liège · General meeting of 27-12-2025 · Gazette deed
Incorporation
Founding capital of €3,000, 100 shares · Founder: STULKO Jennifer Bénédicte Ghislaine · Appointment: STULKO Jennifer Bénédicte Ghislaine (director) · published on 12-04-2022 · Gazette deed
First establishment
Rue des Mésanges 11, Neupré
Official details
Source: KBO- Status
- Active since 08-04-2022Normal situation
- Activity
- “L'exercice de la médecine,et plus particulièrement dans les domaines de la chirurgie orthopédique,par le…” (deed in French)From the articles, 8 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.332.488.9224121 Neupré, since 08-04-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 02-03-2026
Annual accounts 2025
- €401,486▲ 36.4%
- Filing
- Filed on 25-06-2026, 36 days before the end of the filing period
Insights on JS HandSurgery
JS HandSurgery files the micro format. That format states no turnover. The gross margin rose from €105,595 in 2022 to €213,828 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about JS HandSurgery
- What is the company number of JS HandSurgery?
- The company number of JS HandSurgery is 0784.674.669. The VAT number is the same number with BE in front: BE 0784.674.669.
- Where is JS HandSurgery based?
- The registered office is at Rue des Mésanges 11, 4121 Neupré.Company details
- What is the legal form of JS HandSurgery?
- JS HandSurgery is a private limited company (BV).
- When was JS HandSurgery founded?
- JS HandSurgery was founded on 08-04-2022.
- Is JS HandSurgery still active?
- Yes, JS HandSurgery is an active enterprise in the KBO register.
- What is the turnover of JS HandSurgery?
- The turnover in financial year 2025 is ≈ €540,000. This figure is estimated from the gross margin of €213,828 and 2,211 comparable companies of the same size. It probably lies between €360,000 and €820,000. It is a rough estimate.Financials
- Is JS HandSurgery profitable?
- In financial year 2025, JS HandSurgery made a profit of €141,434.
- Where can I find the annual accounts of JS HandSurgery?
- JS HandSurgery filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of JS HandSurgery due?
- JS HandSurgery must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.